Cambridge Cognition Holdings Plc (COG.L) LSE

Currency In GBp

AD

Cambridge Cognition Holdings Plc

Address

Tunbridge Court

Cambridge, CAM CB25 9TU

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 1223 810 700

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Employees

74

First IPO Date

April 18, 2013

Key Executives

NameTitlePayYear Born
Robert BakerCEO, Joint MD & Senior Executive Director201,2431987
James Ronald OpenshawChief Financial Officer, Head of Corporate Development & Director96,0001967
Simon MerrittMarketing and Communications Director0N/A
Francesca CormackChief Scientist & Member of Scientific Advisory Board0N/A
John HammondCo-Founder0N/A
Nick TaptiklisHead of Technology Strategy0N/A
Barbara Sahakian FMedSci FBPsSSenior Consultant0N/A
Trevor RobbinsSenior Consultant0N/A
Simon McKeatingCompany Secretary0N/A
AD

Description

Cambridge Cognition Holdings Plc is a neuroscience technology company focused on developing and globally marketing sophisticated cognitive testing solutions for use in clinical settings. The firm operates internationally, serving clients in the United States, United Kingdom, and European Union, among other regions. Its extensive product portfolio includes CANTAB Recruit, an online platform designed to help pharmaceutical and biotechnology companies efficiently identify and onboard eligible participants for clinical trials, particularly in high-need therapeutic areas such as Alzheimer's disease. For broader pharmaceutical research, CANTAB Connect offers digital cognitive assessment tools applicable across all clinical trial phases (I-IV) and various medical fields. Additionally, the Cognition Kit is a digital health platform that utilizes wearable and smartphone applications to collect data, aiming to boost patient involvement, validate treatment efficacy, and deepen understanding of diseases and individual responses to medication. Other specialized offerings include CANTAB Connect Research, advanced software providing precise digital metrics for cognitive function in brain research; CANTAB Mobile, a touchscreen memory test frequently used in clinical studies pertaining to Alzheimer's disease; and CANTAB BrainHealth, an online digital assessment tool for monitoring mental well-being and cognitive performance in professional environments. The company also provides CANTAB Insight, a medical device for evaluating an individual's cognitive health, and NeuroVocalix, a secure platform enabling automated administration and scoring of validated verbal cognitive assessments. Beyond its technological products, Cambridge Cognition furnishes a suite of expert consultancy and operational management services tailored to enhance clinical trials and cognitive research. These services encompass neuroscience and technical advice, study design, data analysis, comprehensive study and data management, and the provision of insightful reports and interpretations. Cambridge Cognition Holdings Plc was established in 2012 and is headquartered in Cambridge, United Kingdom.

AD